Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cervical cancer
Trial Type:  Prevention
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-24 of 24 for your search:
Start Over
Fenretinide in Treating Patients With Cervical Neoplasia
Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ID92-027, P30CA016672, MDA-ID-92027, NCI-P97-0092, CDR0000065761, NCT00003075
Phase III Randomized Study of Interferon alfa plus Laser Therapy Ablation vs Ablation Alone in Patients with CIN Grades I-III
Phase: Phase III
Type: Prevention, Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-906951, MAYO-906951, NCI-P91-0010
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
Phase: Phase II, Phase I
Type: Prevention
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: J0323 CDR0000439494, R21CA105696, P30CA006973, JHOC-J0323, JHOC-03-05-06-02, NCT00121173
Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00730, 2009-0804, N01CN35159, NCT01021215
Exercise, Smoking Cessation and Adolescents
Phase: Phase II, Phase I
Type: Behavioral study, Prevention
Status: Closed
Age: 13 to 19
Sponsor: NCI, Other
Protocol IDs: R03-CA119712, NCT00297440
Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ID92-026, P30CA016672, MDA-ID-92026, NCI-P00-0149, CDR0000067921, NCT00006079
Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069223, NCCTG-989251, NCI-P02-0208, NCT00031759
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 17 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02513, GOG-0197, U10CA027469, CDR0000269709, NCT00054041
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000347077, AECM-0309225, NCI-5850, 5850, NCT00075569
Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
Phase: Phase II
Type: Prevention, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GOG-0207, NCI-2009-00583, CDR0000360805, U10CA101165, NCT00081263
SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 50
Sponsor: NCI
Protocol IDs: NCI-2012-02623, UCI#02-55, N01CN25139, CDR0000383786, UCIRVINE-02-55, UCIRVINE-2002-2758, NCT00091130
Phase II Randomized Study of Green Tea Extract (Polyphenon E®) for the Prevention of Cervical Cancer in Patients With Human Papillomavirus (HPV) and Low-Grade Cervical Intraepithelial Neoplasia (CIN 1)
Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UARIZ-UAZ03-1-02, UARIZ-HSC-0540, UAZ03-1-02, NCT00303823
Zinc Supplements in Lowering Cadmium Levels in Smokers
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000495325, CCCWFU-98903, CCCWFU-BG03-538, NCT00376987
Folic Acid Clinical Trial for the Prevention of Cervical Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000579360, UAB-F060511015, UAB-IRB0000196, F060511015, NCT00703196
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AMC-054, U01CA121947, CDR0000593634, NCT00667563
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 12 to 26
Sponsor: NCI
Protocol IDs: 090024, 09-C-0024, NCI-09-C-0024, NCI-P07277, NCT00798265
PROS Smokebusters: Adolescent Smoking Cessation in Pediatric Primary Care
Phase: Phase I
Type: Behavioral study, Prevention
Status: Completed
Age: 14 and over
Sponsor: NCI, Other
Protocol IDs: 15677, NCT00135265
UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: Over 14
Sponsor: NCI, Other
Protocol IDs: CDR0000066670, P30CA046592, CCUM-9609, NCI-P98-0131, NCT00003598
Randomized Study of Folic Acid for Chemoprevention of Cervical Cancer (Summary Last Modified 10/89)
Phase: No phase specified
Type: Prevention
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-8745, NCI-P89-0007
Internet and Telephone Counseling for Smoking Cessation
Phase: No phase specified
Type: Behavioral study, Health services research, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000465179, R01CA104836, GUMC-5-R01CA104836, RWMC-5-R01CA104836, NCT00282009
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Phase: No phase specified
Type: Behavioral study, Biomarker/Laboratory analysis, Educational/Counseling/Training, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 10332, R01CA091912, KUMC-HSC-10332, KUMC-070313, NCT00666978
Smoking Cessation for HIV/AIDS Patients
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2003-0784, NCI-2012-02109, NCT00502827
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
Phase: No phase specified
Type: Natural history/Epidemiology, Prevention
Status: Completed
Age: 21 to 30
Sponsor: NCI
Protocol IDs: 999910059, 10-C-N059, NCT01086709
Increasing Contingency Management Success in Smoking Cessation
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 045-0013-195, R01DA013304, NCT00273793
Start Over